Market participants will be watching February’s CPI inflation data this morning for signs of whether price pressures have eased, which will be key for the Federal Reserve to start cutting interest rates; Oracle (ORCL) shares are soaring on its quarterly earnings beat; Acadia Pharmaceuticals (ACAD) is slumping after its schizophrenia drug failed to meet late-stage trial goals; U.S. air safety regulators reportedly found “dozens of problems” at Boeing (BA) facilities and one of its key suppliers; and Chinese mobile-phone maker Xiaomi is planning to launch its first electric vehicle. Ahead of today's crucial consumer price inflation report, U.S. equity futures are mixed, while bitcoin remains over $72,000. Here’s what investors need to know today.

1. February CPI Seen Rising 3.1% Year-Over-Year

Investors will be watching February inflation data, due at 8:30 a.m. ET, for indications about the U.S. consumer’s health after January’s hotter-than-forecast numbers—a data point that convinced investors the Federal Reserve wouldn't be able to move quickly to cut interest rates. Today's Consumer Price Index report is expected to show that prices rose 3.1% over the previous 12 months in February, the same annual rate as in January, while “core” inflation, which excludes volatile prices for food and energy, is predicted to have declined to 3.7% over the year, down from 3.9% in January, according to a survey of economists by Dow Jones Newswires and the Wall Street Journal. A CPI report that meets forecasts may leave the Fed on track to begin rolling back its campaign of anti-inflation interest rate hikes in June.

2. Oracle Jumps on Earnings Beat, AI-Cloud Infrastructure Demand

Shares in Oracle (ORCL) were more than 13% higher about two hours before Tuesday's opening bell, after the enterprise-computing-solutions provider reported better-than-expected quarterly earnings and said signups continued for its AI-fueled cloud infrastructure. Oracle said it expects revenue in the current quarter to grow between 4% and 6%, with CEO Safra Catz noting that it has several large new cloud infrastructure contracts in the pipeline as demand for its “Gen2 AI infrastructure substantially exceeds supply.”

3. Acadia Shares Tumble After Failed Schizophrenia Drug Trial

Shares of Acadia Pharmaceuticals (ACAD) plunged more than 16% in premarket trading, after the biotech firm said one of its drugs for treating schizophrenia had failed to meet goals of a late-stage trial. Acadia’s pimavanserin, marketed as Nuplazid, did not demonstrate a statistically significant improvement over a placebo in treating some symptoms of schizophrenia, the company said. “We are disappointed the trial did not meet its primary endpoint given the significant unmet need in patients with negative symptoms of schizophrenia,” CEO Steve Davis said in a statement.

4. Safety Regulators Flag Dozens of Problems at Boeing

Boeing (BA) shares slipped more than 1% in premarket trading as the aircraft maker faced a new onslaught of bad news, with The New York Times reporting that U.S. air safety regulators found “dozens of problems” at facilities owned by the company and one of its key suppliers after a six-week audit of the production of the 737 Max jet. That follows reports of injuries from a "technical problem" on a LATAM flight involving a Boeing aircraft and a Department of Justice (DOJ) investigation into a Jan. 5 Alaska Airlines (ALK) flight where a door panel came loose from a plane. Boeing shares are down more than 20% this year.

5. Chinese Mobile-Phone Maker Xiaomi Set to Launch First EV This Month

Chinese mobile-phone maker Xiaomi will launch its first electric vehicle this month, a four-door tech-laden sedan that it hopes will draw consumers at a time when EV sales in China are slowing amid intense domestic competition. The company, best known for its popular smartphones and home appliances, will launch its SU7 model on March 28 in China, chief executive Lei Jun said in a post on his Weibo account Tuesday, according to The Wall Street Journal. The Chinese mobile phone company’s foray into EVs just comes just weeks after Apple (AAPL) ended its quest to build its own EV.